Sanofi
SNY
532 hedge funds and large institutions have $9.01B invested in Sanofi in 2019 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 178 increasing their positions, 151 reducing their positions, and 42 closing their positions.
377% more call options, than puts
Call options by funds: $85.7M | Put options by funds: $18M
126% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 42
18% more repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 151
10% more funds holding
Funds holding: 485 → 532 (+47)
9% more capital invested
Capital invested by funds: $8.28B → $9.01B (+$726M)
0.04% more ownership
Funds ownership: 14.27% → 14.31% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$209M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$122M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$75.3M |
| 4 |
CI
Cambiar Investors
Denver,
Colorado
|
+$43.9M |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$438M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$85M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.8M |
| 4 |
Morgan Stanley
New York
|
-$25.7M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$8.71M |
SNY Hedge Fund Activity: Q4 2019 in Review
532 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2019, worth a combined $9.01B — up 8.8% from $8.28B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new SNY positions and 42 closed out — a net gain of 53 holders — while 178 added to existing stakes and 151 trimmed.
The largest buyer was BlackRock, adding an estimated $209M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $438M.
- 532 institutional investors held Sanofi (SNY) as of Q4 2019, up from 485 in Q3 2019.
- Funds reported $9.01B of Sanofi stock for Q4 2019, up 8.8% quarter-over-quarter.
- 95 funds opened new Sanofi positions in Q4 2019 and 42 closed out, a net change of +53 holders.
- The largest Sanofi buyer in Q4 2019 was BlackRock, an estimated $209M added.
- The largest Sanofi seller in Q4 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $438M sold.
Based on aggregated 13F filings for Q4 2019.